These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21116420)

  • 1. Diabetic nephropathy and chronic kidney disease at a busy diabetes clinic: a study of outpatient care and suggestions for improved care pathways at a subspecialty specialist diabetic renal clinic.
    Graham UM; Magee GM; Hunter SJ; Atkinson AB
    Ulster Med J; 2010 May; 79(2):57-61. PubMed ID: 21116420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective review of diabetic nephropathy patients during referral to the sub-urban nephrology clinic.
    Menon R; Mohd Noor FS; Draman CR; Seman MR; Ghani AS
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):1109-14. PubMed ID: 22982937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
    Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Population-Based Analysis of Quality Indicators in CKD.
    Manns L; Scott-Douglas N; Tonelli M; Weaver R; Tam-Tham H; Chong C; Hemmelgarn B
    Clin J Am Soc Nephrol; 2017 May; 12(5):727-733. PubMed ID: 28377473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25).
    Yokoyama H; Araki S; Haneda M; Matsushima M; Kawai K; Hirao K; Oishi M; Sugimoto K; Sone H; Maegawa H; Kashiwagi A;
    Diabetologia; 2012 Jul; 55(7):1911-8. PubMed ID: 22476921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD.
    Navaneethan SD; Akeroyd JM; Ramsey D; Ahmed ST; Mishra SR; Petersen LA; Muntner P; Ballantyne C; Winkelmayer WC; Ramanathan V; Virani SS
    Clin J Am Soc Nephrol; 2018 Dec; 13(12):1842-1850. PubMed ID: 30498000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
    Ivory SE; Packham DK; Reutens AT; Wolfe R; Rohde RD; Lewis J; Atkins RC;
    Nephrology (Carlton); 2013 Jul; 18(7):516-24. PubMed ID: 23506627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate of decline of GFR and progression of vascular disease in type 2 diabetic patients with diabetic or vascular nephropathy during the last three years before starting dialysis therapy.
    Biesenbach G; Schmekal B; Pieringer H; Janko O
    Kidney Blood Press Res; 2006; 29(5):267-72. PubMed ID: 17035711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
    Yamanouchi M; Skupien J; Niewczas MA; Smiles AM; Doria A; Stanton RC; Galecki AT; Duffin KL; Pullen N; Breyer MD; Bonventre JV; Warram JH; Krolewski AS
    Kidney Int; 2017 Jul; 92(1):258-266. PubMed ID: 28396115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
    Wada T; Haneda M; Furuichi K; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Shimizu M; Toyama T; Hara A; Makino H;
    Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-risk diabetic nephropathy patients: the outcome of evidence-based clinical practice in an outpatient clinic.
    Slade H; Williams SM; Manning PJ; Walker RJ
    Diabetes Res Clin Pract; 2011 Jun; 92(3):356-60. PubMed ID: 21411171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic nephropathy: how effective is treatment in clinical practice?
    Joss N; Paterson KR; Deighan CJ; Simpson K; Boulton-Jones JM
    QJM; 2002 Jan; 95(1):41-9. PubMed ID: 11834772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus.
    Penno G; Russo E; Garofolo M; Daniele G; Lucchesi D; Giusti L; Sancho Bornez V; Bianchi C; Dardano A; Miccoli R; Del Prato S
    Diabetologia; 2017 Jun; 60(6):1102-1113. PubMed ID: 28357502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand.
    Lloyd H; Li G; Tomlin A; Tilyard MW; Walker R; Schollum J
    Nephrology (Carlton); 2019 Mar; 24(3):308-315. PubMed ID: 29717528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study.
    Cid Ruzafa J; Paczkowski R; Boye KS; Di Tanna GL; Sheetz MJ; Donaldson R; Breyer MD; Neasham D; Voelker JR
    Int J Clin Pract; 2015 Aug; 69(8):871-82. PubMed ID: 26011029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal function markers and metformin eligibility.
    Tavares Bello C; Castro Fonseca R; Sousa Santos F; Sequeira Duarte J; Azinheira J; Vasconcelos C
    Minerva Endocrinol; 2018 Sep; 43(3):246-252. PubMed ID: 28565889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are gatekeepers to renal services referring patients equitably?
    Kee F; Reaney E; Savage G; O'Reilly D; Patterson C; Maxwell P; Fogarty D;
    J Health Serv Res Policy; 2007 Jan; 12(1):36-41. PubMed ID: 17244396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
    Pugliese G; Penno G; Natali A; Barutta F; Di Paolo S; Reboldi G; Gesualdo L; De Nicola L;
    Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1127-1150. PubMed ID: 31586514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slowing renal function decline in chronic kidney disease patients after nephrology referral.
    Chen SC; Chang JM; Chou MC; Lin MY; Chen JH; Sun JH; Guh JY; Hwang SJ; Chen HC
    Nephrology (Carlton); 2008 Dec; 13(8):730-6. PubMed ID: 19019170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.